Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

A Phase 3 Biomarker Validation of GALAD for the Detection of Hepatocellular Carcinoma in Cirrhosis.

Autor: Marsh TL; Biostatistics Program, Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washinton., Parikh ND; Division of Gastroenterology and Hepatology, University of Michigan, Ann Arbor, Michigan., Roberts LR; Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine and Science, Rochester, Minnesota., Schwartz ME; Recanati/Miller Transplant Institute, Mt Sinai Medical Center, New York, New York., Nguyen MH; Division of Gastroenterology and Hepatology and Department of Epidemiology and Population Health, Stanford University, Palo Alto, California., Befeler A; Division of Gastroenterology, Saint Louis University, St. Louis, Missouri., Page-Lester S; Biostatistics Program, Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washinton., Tayob N; Department of Data Science, Dana Farber Cancer Institute, Boston, Massachusetts., Srivastava S; Cancer Biomarkers Research Group, Division of Cancer Prevention, National Cancer Institute, Bethesda, Maryland., Rinaudo JA; Cancer Biomarkers Research Group, Division of Cancer Prevention, National Cancer Institute, Bethesda, Maryland., Singal AG; Division of Digestive and Liver Disease, UT Southwestern, Dallas, Texas; (10)Division of Gastroenterology and Hepatology, University of Pennsylvania, Philadelphia, Pennsylvania., Reddy KR; Biostatistics Program, Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washinton., Marrero JA; Biostatistics Program, Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washinton. Electronic address: jorge.marrero@pennmedicine.upenn.edu.

Publikováno v: Gastroenterology [Gastroenterology] 2024 Sep 16. Date of Electronic Publication: 2024 Sep 16.

A Reduced Pancreatic Polypeptide Response is Associated With New-onset Pancreatogenic Diabetes Versus Type 2 Diabetes.

Autor: Hart PA; Division of Gastroenterology, Hepatology, and Nutrition, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USA., Kudva YC; Division of Endocrinology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA., Yadav D; Division of Gastroenterology, Hepatology and Nutrition, University of Pittsburgh Medical Center, Pittsburgh, PA 15213, USA., Andersen DK; Division of Digestive Diseases and Nutrition, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20814, USA., Li Y; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Toledo FGS; Division of Endocrinology and Metabolism, Department of Medicine, University of Pittsburgh, Pittsburgh, PA 15213, USA., Wang F; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Bellin MD; Departments of Pediatrics and Surgery, University of Minnesota Medical School, Minneapolis, MN 55455, USA., Bradley D; Diabetes and Metabolism Research Center, Division of Endocrinology, Diabetes & Metabolism, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USA., Brand RE; Division of Gastroenterology, Hepatology and Nutrition, University of Pittsburgh Medical Center, Pittsburgh, PA 15213, USA., Cusi K; Division of Endocrinology & Metabolism, University of Florida, Gainesville, FL 32611, USA., Fisher W; Department of Surgery, Baylor College of Medicine, Houston, TX 77030, USA., Mather K; Division of Endocrinology, Indiana University School of Medicine, Indianapolis, IN 46202, USA., Park WG; Division of Gastroenterology & Hepatology, Stanford University School of Medicine, Stanford, CA 94305, USA., Saeed Z; Division of Endocrinology, Indiana University School of Medicine, Indianapolis, IN 46202, USA., Considine RV; Division of Endocrinology, Indiana University School of Medicine, Indianapolis, IN 46202, USA., Graham SC; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Rinaudo JA; Cancer Biomarker Research Group, Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Rockville, MD 20850, USA., Serrano J; Division of Digestive Diseases and Nutrition, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20814, USA., Goodarzi MO; Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.

Publikováno v: The Journal of clinical endocrinology and metabolism [J Clin Endocrinol Metab] 2023 Apr 13; Vol. 108 (5), pp. e120-e128.

Imaging of the Pancreas in New-Onset Diabetes: A Prospective Pilot Study.

Autor: Wu BU; Center for Pancreatic Care, Kaiser Permanente Los Angeles Medical Center, Los Angeles, California, USA., Lustigova E; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA., Chen Q; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA., Dong EY; Center for Pancreatic Care, Kaiser Permanente Los Angeles Medical Center, Los Angeles, California, USA., Maitra A; University of Texas, MD Anderson Cancer Center, Houston, Texas, USA., Chari ST; University of Texas, MD Anderson Cancer Center, Houston, Texas, USA., Feng Z; Fred Hutchinson Cancer Center, Seattle, Washington, USA., Rinaudo JA; National Cancer Institute, Division of Cancer Prevention, National Cancer Institute, Bethesda, MD, USA., Matrisian LM; Pancreatic Cancer Action Network, Manhattan Beach, California, USA., Parker RA; Department of Radiology, Kaiser Permanente Los Angeles Medical Center, Los Angeles, California, USA.

Publikováno v: Clinical and translational gastroenterology [Clin Transl Gastroenterol] 2022 Jun 01; Vol. 13 (6), pp. e00478. Date of Electronic Publication: 2022 Jun 01.

International Liver Cancer Association (ILCA) White Paper on Biomarker Development for Hepatocellular Carcinoma.

Autor: Singal AG; Division of Digestive and Liver Diseases, Department of Internal Medicine, UT Southwestern Medical Center, Dallas, Texas, Texas. Electronic address: amit.singal@utsouthwestern.edu., Hoshida Y; Division of Digestive and Liver Diseases, Department of Internal Medicine, UT Southwestern Medical Center, Dallas, Texas, Texas., Pinato DJ; Department of Surgery & Cancer, Imperial College London, Hammersmith Hospital, London, UK., Marrero J; Division of Digestive and Liver Diseases, Department of Internal Medicine, UT Southwestern Medical Center, Dallas, Texas, Texas., Nault JC; Service d'hépatologie, Hôpital Jean Verdier, Hôpitaux Universitaires Paris-Seine-Saint-Denis, Assistance-Publique Hôpitaux de Paris, Bondy, France; Unité de Formation et de Recherche Santé Médecine et Biologie Humaine, Université Paris 13, Paris, France; Centre de Recherche des Cordeliers, Inserm, Sorbonne Université, Université Paris, INSERM UMR 118 Functional Genomics of Solid Tumors Laboratory, F-75006, Paris, France., Paradis V; Pathology Department, Beaujon hospital, Clichy, University Paris, France., Tayob N; Department of Data Science, Dana Farber Cancer Institute, Department of Medicine, Harvard Medical School, Boston, Massachusetts., Sherman M; University Health Network, Toronto, Ontario, Canada., Lim YS; Department of Gastroenterology, Liver Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea., Feng Z; Biostatistics Program, Public Health Science Division, Fred Hutchinson Cancer Research Center, Seattle, Washington., Lok AS; Division of Gastroenterology and Hepatology, University of Michigan, Ann Arbor, Michigan., Rinaudo JA; Cancer Biomarker Research Group, Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Rockville, Maryland., Srivastava S; Cancer Biomarker Research Group, Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Rockville, Maryland., Llovet JM; Division of Liver Diseases and Hematology/Medical Oncology, Liver Cancer Program, Tisch Cancer Institute, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York; Translational Research in Hepatic Oncology, Liver Unit, IDIBAPS, Hospital Clinic, University of Barcelona, Catalonia, Spain; Institució Catalana d'Estudis Avançats (ICREA), Barcelona, Catalonia, Spain., Villanueva A; Division of Liver Diseases and Hematology/Medical Oncology, Liver Cancer Program, Tisch Cancer Institute, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York. Electronic address: augusto.villanueva@mssm.edu.

Publikováno v: Gastroenterology [Gastroenterology] 2021 Jun; Vol. 160 (7), pp. 2572-2584. Date of Electronic Publication: 2021 Mar 09.